ANNEXU.K. Format for applications, as provided for in Article 2(1)
The application shall be in writing, signed by the applicant, and sent to the rapporteur Member State and to the co-rapporteur Member State.
A copy of the application shall be sent to the European Commission, DG Health and Consumers, 1049 Brussels, Belgium, to the European Food Safety Authority, Via Carlo Magno 1/A, 43126 Parma, Italy and to the other Member States.
MODELU.K.
1.Information concerning the applicantU.K.
1.1.Name and address of the applicant including the name of the natural person responsible for the application and other obligations resulting from this Regulation:U.K.
1.1.1.
(a)
Telephone No:
(b)
E-mail address:
1.1.2.
(a)
Contact:
(b)
Alternative contact:
2.Information to facilitate identificationU.K.
2.1.Common name (proposed or ISO-accepted) specifying, where relevant, any variants thereof such as salts, esters or amines manufactured by the producer.U.K.
2.2.Chemical name (IUPAC and CAS nomenclature).U.K.
2.3.CAS, CIPAC and EC numbers (if available).U.K.
2.4.Empirical and structural formula, molecular mass.U.K.
2.5.Specification of purity of the active substance in g/kg which must be, whenever possible, identical or already accepted as equivalent to the one listed in the Annex to Commission Implementing Regulation (EU) No 540/2011(1).U.K.
2.6.Classification and labelling of the active substance in accordance with the provisions of Regulation (EC) No 1272/2008 of the European Parliament and of the Council(2) (health and environment effects).U.K.
3.New informationU.K.
3.1.List of new information intended to be submitted together with a justification showing that they are considered necessary, in accordance with Article 15(2) of Regulation (EC) No 1107/2009.U.K.
3.2.List of new studies intended to be submitted on vertebrate animals.U.K.
3.3.Timetable of any new and ongoing studies.U.K.
The applicant confirms that the above information submitted included in the application is correct.
Date and signature (of the person competent to act for the applicant referred to under point 1.1).